Measuring productivity loss in early relapsing-remitting multiple sclerosis
Sainz de la Maza, Susana ; Maurino, Jorge ; Borges, Mónica ; Martín-Martínez, Jesús ; Sotoca, Javier ; Alonso, Ana ; Caminero, Ana B. ; Borrega, Laura ; Sánchez-Menoyo, José L. ; Barrero-Hernández, Francisco J. ; Calles, Carmen ; Brieva, Luis ; Blasco, Maria R. ; Dotor García-Soto, Julio ; Campo-Amigo, María del ; Navarro-Cantó, Laura ; Agüera, Eduardo ; Garcés, Moisés (Universidad de Zaragoza) ; Carmona, Olga ; Gabaldón-Torres, Laura ; Forero, Lucía ; Hervás, Mariona ; Ruiz de Alda, Lucía ; Gómez-Ballesteros, Rocío ; Castillo-Triviño, Tamara
Resumen: Background
Multiple sclerosis is one of the most common causes of neurological disability in young adults with major consequences for their autonomy and capacity to maintain employment.
Objective
The aim of this study was to assess the impact on work productivity in early-stage relapsing-remitting multiple sclerosis (RRMS).
Methods
A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were included. Absenteeism, presenteeism, and unpaid work loss due to RRMS were measured using the Valuation of Lost Productivity (VOLP) questionnaire. The EDSS, SymptoMScreen, 5-item Modified Fatigue Impact Scale, Hospital Anxiety and Depression Scale, Symbol Digit Modalities Test, and Multiple Sclerosis Work Difficulties Questionnaire were used to gather information on disability, patients’ perception of symptom severity, fatigue, mood/anxiety, cognition, and problems in the workplace, respectively. Associations between the VOLP and clinical and work outcomes were analyzed using Spearman's rank correlations.
Results
A total of 189 patients were included. Mean age (SD) was 36.1 ± 9.4 years and 71.4% were female. Mean disease duration was 1.2 ± 0.8 years. Median EDSS score was 1.0 (IQR 0, 2.0). One hundred thirty patients (68.8%) were working for pay or self-employed. Fifty-three patients (40.8%) reported absence from work in the past 3 months with an average of 14.3 absent workdays. Their health problems resulted in the loss of 3.4% of their actual work time in the past 7 days. Thirty patients got help (11.8 h) with their unpaid work activities in the past 7 days. Absenteeism was significantly correlated with anxiety and depression (rho=0.298 and 0.291, p<0.001), fatigue (rho=0.214, p = 0.014), and symptom severity (rho=0.213, p = 0.015). Presenteeism was significantly correlated with fatigue (rho=0.375, p<0.001), symptom severity (rho=0.373, p<0.001), depression (rho=0.263, p = 0.008), and disability (rho=0.215, p = 0.031).
Conclusions
Productivity loss even in a RRMS population with short disease duration stresses the need for more efficient treatment control of disease activity from earlier stages.
Idioma: Inglés
DOI: 10.1016/j.msard.2021.103398
Año: 2022
Publicado en: Multiple Sclerosis and Related Disorders 58 (2022), 103398 [5 pp.]
ISSN: 2211-0348
Factor impacto JCR: 4.0 (2022)
Categ. JCR: CLINICAL NEUROLOGY rank: 69 / 212 = 0.325 (2022) - Q2 - T1
Factor impacto CITESCORE: 5.6 - Neuroscience (Q2) - Medicine (Q1)
Factor impacto SCIMAGO: 0.92 - Medicine (miscellaneous) (Q1) - Neurology (clinical) (Q2) - Neurology (Q2)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
All rights reserved by journal editor
Exportado de SIDERAL (2024-03-18-17:06:57)
Visitas y descargas
Multiple sclerosis is one of the most common causes of neurological disability in young adults with major consequences for their autonomy and capacity to maintain employment.
Objective
The aim of this study was to assess the impact on work productivity in early-stage relapsing-remitting multiple sclerosis (RRMS).
Methods
A multicenter, non-interventional study was conducted. Adult patients with a diagnosis of RRMS, a disease duration ≤ 3 years, and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were included. Absenteeism, presenteeism, and unpaid work loss due to RRMS were measured using the Valuation of Lost Productivity (VOLP) questionnaire. The EDSS, SymptoMScreen, 5-item Modified Fatigue Impact Scale, Hospital Anxiety and Depression Scale, Symbol Digit Modalities Test, and Multiple Sclerosis Work Difficulties Questionnaire were used to gather information on disability, patients’ perception of symptom severity, fatigue, mood/anxiety, cognition, and problems in the workplace, respectively. Associations between the VOLP and clinical and work outcomes were analyzed using Spearman's rank correlations.
Results
A total of 189 patients were included. Mean age (SD) was 36.1 ± 9.4 years and 71.4% were female. Mean disease duration was 1.2 ± 0.8 years. Median EDSS score was 1.0 (IQR 0, 2.0). One hundred thirty patients (68.8%) were working for pay or self-employed. Fifty-three patients (40.8%) reported absence from work in the past 3 months with an average of 14.3 absent workdays. Their health problems resulted in the loss of 3.4% of their actual work time in the past 7 days. Thirty patients got help (11.8 h) with their unpaid work activities in the past 7 days. Absenteeism was significantly correlated with anxiety and depression (rho=0.298 and 0.291, p<0.001), fatigue (rho=0.214, p = 0.014), and symptom severity (rho=0.213, p = 0.015). Presenteeism was significantly correlated with fatigue (rho=0.375, p<0.001), symptom severity (rho=0.373, p<0.001), depression (rho=0.263, p = 0.008), and disability (rho=0.215, p = 0.031).
Conclusions
Productivity loss even in a RRMS population with short disease duration stresses the need for more efficient treatment control of disease activity from earlier stages.
Idioma: Inglés
DOI: 10.1016/j.msard.2021.103398
Año: 2022
Publicado en: Multiple Sclerosis and Related Disorders 58 (2022), 103398 [5 pp.]
ISSN: 2211-0348
Factor impacto JCR: 4.0 (2022)
Categ. JCR: CLINICAL NEUROLOGY rank: 69 / 212 = 0.325 (2022) - Q2 - T1
Factor impacto CITESCORE: 5.6 - Neuroscience (Q2) - Medicine (Q1)
Factor impacto SCIMAGO: 0.92 - Medicine (miscellaneous) (Q1) - Neurology (clinical) (Q2) - Neurology (Q2)
Tipo y forma: Article (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
All rights reserved by journal editorExportado de SIDERAL (2024-03-18-17:06:57)
Permalink:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Medicina
Record created 2024-02-19, last modified 2024-03-19